An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
  • Published Date:

    February 25 2014

  • Source:
    J Infect Dis. 2014; 210(3):435-440
  • Language:
    English
Filetype[PDF-816.01 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 1.04 MB]
    Personal Author:
    Marjuki, Henju; Mishin, Vasiliy P.; Chesnokov, Anton P.; Jones, Joyce; De La Cruz, Juan A.; Sleeman, Katrina; Tamura, Daisuke; Nguyen, Ha T.; Wu, Ho-Sheng; Chang, Feng-Yee; Liu, Ming-Tsan; Fry, Alicia M.; Cox, Nancy J.; Villanueva, Julie M.; Davis, Charles T.; Gubareva, Larisa V.;
    Published Date:
    August 14 2014
    Source:
    J Infect Dis. 211(2):249-257
    Description:
    Background.Patients contracting influenza A(H7N9) infection often developed severe disease causing respiratory failure. Neuraminidase (NA) inhibitors (NAIs) are the primary option for treatment, but information on drugresistance markers for influenza...
    File Type:
    Filetype[PDF - 1.04 MB]
  2. Filetype[PDF - 562.27 KB]
    Personal Author:
    Sleeman, Katrina; Guo, Zhu; Barnes, John; Shaw, Michael; Stevens, James; Gubareva, Larisa V.;
    Published Date:
    2013
    Source:
    Emerg Infect Dis. 19(9):1521-1524.
    Description:
    Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According to a neuraminidase inhibition assay, an R292K substitution reduced antiviral efficacy of inhibitors,...
    File Type:
    Filetype[PDF - 562.27 KB]
  3. Filetype[PDF - 1.06 MB]
    Personal Author:
    Wilson, Jason R.; Guo, Zhu; Reber, Adrian; Kamal, Ram P.; Music, Nedzad; Gansebom, Shane; Bai, Yaohui; Levine, Min; Carney, Paul; Tzeng, Wen-Pin; Stevens, James; York, Ian A.;
    Published Date:
    Oct 03 2016
    Source:
    Antiviral Res. 135:48-55.
    Description:
    Zoonotic A(H7N9) avian influenza viruses emerged in China in 2013 and continue to be a threat to human public health, having infected over 800 individuals with a mortality rate approaching 40%. Treatment options for people infected with A(H7N9) inclu...
    File Type:
    Filetype[PDF - 1.06 MB]
  4. Filetype[PDF - 2.73 MB]
    Personal Author:
    Yamayoshi, Seiya; Kiso, Maki; Yasuhara, Atsuhiro; Ito, Mutsumi; Shu, Yuelong; Kawaoka, Yoshihiro;
    Published Date:
    Apr 2018
    Source:
    Emerg Infect Dis. 24(4):746-750.
    Description:
    To clarify the threat posed by emergence of highly pathogenic influenza A(H7N9) virus infection among humans, we characterized the viral polymerase complex. Polymerase basic 2-482R, polymerase basic 2-588V, and polymerase acidic-497R individually or ...
    File Type:
    Filetype[PDF - 2.73 MB]
  5. Filetype[PDF - 611.49 KB]
    Personal Author:
    Yuan, Jun; Lau, Eric H.Y.; Li, Kuibiao; Leung, Y.H. Connie; Yang, Zhicong; Xie, Caojun; Liu, Yufei; Liu, Yanhui; Ma, Xiaowei; Liu, Jianping; Li, Xiaoquan; Chen, Kuncai; Luo, Lei; Di, Biao; Cowling, Benjamin J.; Tang, Xiaoping; Leung, Gabriel M.; Wang, Ming; Peiris, Malik;
    Published Date:
    Oct 2015
    Source:
    Emerg Infect Dis. 21(10):1784-1793
    Description:
    We assessed the effect of closing live poultry markets in China on influenza A(H7N9) virus detection and viability. Intensive sampling was carried out before, during, and after a 2-week citywide market closure; the markets were cleaned and disinfecte...
    File Type:
    Filetype[PDF - 611.49 KB]